Jarrod A Keeler, MD
Otolaryngology · Bethlehem
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Specialty Physician Associates, LLC · St Lukes Physician Group Inc
Hospitals listed: St Luke'S Hospital Bethlehem · St Luke'S Hospital - Monroe Campus. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Keeler’s office at (570) 645-1540 to ask if they take your plan before you enroll.
California Medical Board record
Licence A136329 · Cancelled
Licence status: Cancelled · since 2015 · University of South Florida College of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- St Luke'S Hospital - Monroe CampusStroudsburg, PAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Saint Lukes University Health Network, which runs 11 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.205, Oct 2024 – Sep 2025
- St Lukes HospitalBethlehem, PAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Saint Lukes University Health Network, which runs 11 hospitals in 2 statesPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.61 (0.31 to 0.91), Jul 2022 – Jun 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 95.36 (56.14 to 134.58) · 194 cases, Jul 2022 – Jun 2024Better than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 1.97 (0.53 to 3.41) · 4,413 cases, Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.13 (0 to 0.54) · 12,350 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.244, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.225, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.202, Oct 2024 – Sep 2025
See every measure and the patient survey for St Luke'S Hospital - Monroe Campus
Behind the star rating — Deaths: 1 better, 5 the same, 0 worse of 6 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.205 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 756 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.45 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 125 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.4 · 76 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.4 · 376 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 352 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 157 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 2,272 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.08 to 0.51) · 4,762 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.03 to 0.44) · 4,869 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.31 (0.91 to 5.71) · 536 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 39 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.38 (0.74 to 4.01) · 507 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.97 (0 to 18.93) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (0.84 to 9.46) · 36 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.17) · 145 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 1.03) · 3,743 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.7 · 39 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.387 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.955 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.486 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.2 · 93 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 25 · 611 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -0.4 · 64 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 13.5 · 425 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8.1 · 342 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6 (4 to 8.8) · 95 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.4 to 13.7) · 95 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 42 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 256 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.8 to 15.8) · 2,117 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 177 cases | No different | Jan 2024 – Dec 2024 |
What patients said (935 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for St Lukes Hospital
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 5 better, 3 the same, 0 worse of 8 measures. Readmissions: 0 better, 8 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.61 (0.31 to 0.91) | Better | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 95.36 (56.14 to 134.58) · 194 cases | Better | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 1.97 (0.53 to 3.41) · 4,413 cases | Better | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.13 (0 to 0.54) · 12,350 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.244 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.225 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.202 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.65 (0 to 1.4) · 2,827 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.6 · 195 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.8 · 217 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 201 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.4 · 818 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.3 · 604 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 531 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,474 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.08 (0 to 0.23) · 14,123 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.07 to 0.41) · 14,906 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 330 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.37 (0.26 to 2.48) · 3,916 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.01 (0 to 14.17) · 336 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.47 (0.46 to 8.48) · 310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.26 (0 to 2.56) · 789 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 216 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.699 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.137 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 364 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.4 · 1,364 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -11.5 · 267 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 42.8 · 1,008 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 29 · 655 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.4 · 1,010 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.6 (3.3 to 6.4) · 357 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.9 to 15.1) · 357 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.4 · 227 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 172 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 417 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.3 (10.6 to 16.6) · 2,486 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.3) · 1,809 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,011 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 80% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$123,203
Medicare paid this office $123,203 for 348 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 177 | $15,706 | $64 |
| Insertion of hypoglossal nerve neurostimulator electrode and generator and breathing sensor electrode | 15 | $9,912 | $661 |
| New patient visit (30+ min) | 85 | $6,442 | $76 |
| Diagnostic exam of nasal passages using an endoscope | 30 | $5,509 | $122 |
| Short return visit | 90 | $5,438 | $42 |
See all 10 services
| Short return visit (20+ min) | 177 | $15,706 | $64 |
| Insertion of hypoglossal nerve neurostimulator electrode and generator and breathing sensor electrode | 15 | $9,912 | $661 |
| New patient visit (30+ min) | 85 | $6,442 | $76 |
| Diagnostic exam of nasal passages using an endoscope | 30 | $5,509 | $122 |
| Short return visit | 90 | $5,438 | $42 |
| Diagnostic exam of voice box using a flexible endoscope | 24 | $2,319 | $93 |
| Removal of impacted ear wax | 36 | $1,291 | $33 |
| Evaluation of sleep-disordered breathing by examination of upper airway using an endoscope | 18 | $1,278 | $71 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $989 | $66 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $633 | $40 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 24 | More than 77% of doctors who do this |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
348 Original Medicare patients in 2024. Average age 73 · Under 65 7% · 85 and older 10% · Women 47% · Also on Medicaid 7% · Health risk score 1.35. Above the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 75% · Chronic kidney disease 32% · Diabetes 29% · Coronary heart disease 28% · Depression 28% · Atrial fibrillation 22% · Heart failure 18% · Cancer 18% · COPD 18% · Stroke 10% · Dementia 5%.
The office billed $384,858, Medicare allowed $160,378 and paid $123,203; for 2,141 services of 79 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 348 | 2,141 | 73 | 1.35 | $384,858 | $123,203 |
| 2023 | 319 | 2,081 | 73 | 1.40 | $415,283 | $115,731 |
| 2022 | 288 | 1,778 | 74 | 1.37 | $318,081 | $96,562 |
| 2021 | 463 | 2,275 | 73 | 1.35 | $459,293 | $144,328 |
| 2020 | 432 | 2,077 | 73 | 1.33 | $340,335 | $100,485 |
| 2019 | 391 | 1,461 | 73 | 1.49 | $456,701 | $119,012 |
| 2018 | 435 | 1,711 | 72 | 1.34 | $360,804 | $110,512 |
| 2017 | 427 | 1,501 | 73 | 1.50 | $392,703 | $119,213 |
| 2016 | 181 | 372 | 74 | 1.48 | $104,075 | $32,502 |
| 2015 | 27 | 38 | 69 | 1.28 | $14,779 | $2,490 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Short return visit (20+ min) | 163 | $16,039 | $65 |
| Insertion of hypoglossal nerve neurostimulator electrode and generator and breathing sensor electrode | 17 | $11,064 | $651 |
| New patient visit (30+ min) | 94 | $7,546 | $80 |
| Diagnostic exam of nasal passages using an endoscope | 38 | $6,954 | $136 |
| Short return visit | 80 | $4,419 | $40 |
| New patient visit (45+ min) | 18 | $2,175 | $121 |
| Diagnostic exam of voice box using a flexible endoscope | 21 | $2,081 | $90 |
| Evaluation of sleep-disordered breathing by examination of upper airway using an endoscope | 30 | $2,059 | $69 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,152 | $64 |
| Punch biopsy, first skin growth | 11 | $1,046 | $95 |
| Removal of impacted ear wax | 26 | $960 | $31 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $687 | $38 |
2022: 10 services
| Short return visit (20+ min) | 151 | $14,582 | $67 |
| Insertion of hypoglossal nerve neurostimulator electrode and generator and breathing sensor electrode | 12 | $8,105 | $675 |
| Diagnostic exam of nasal passages using an endoscope | 40 | $7,379 | $139 |
| New patient visit (30+ min) | 72 | $5,550 | $77 |
| New patient visit (45+ min) | 40 | $4,374 | $109 |
| Short return visit | 60 | $3,181 | $44 |
| Return visit (30+ min) | 26 | $2,206 | $82 |
| Diagnostic exam of voice box using a flexible endoscope | 20 | $2,034 | $97 |
| Evaluation of sleep-disordered breathing by examination of upper airway using an endoscope | 19 | $1,609 | $85 |
| Removal of impacted ear wax | 30 | $1,168 | $33 |
2021: 13 services
| Short return visit (20+ min) | 218 | $22,270 | $67 |
| New patient visit (45+ min) | 114 | $13,939 | $122 |
| Return visit (30+ min) | 103 | $11,518 | $96 |
| Implantation of cranial nerve neurostimulator electrodes and generator | 16 | $7,660 | $479 |
| Diagnostic exam of nasal passages using an endoscope | 38 | $7,602 | $133 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | 13 | $6,679 | $477 |
| New patient visit (30+ min) | 77 | $5,924 | $77 |
| Diagnostic exam of voice box using a flexible endoscope | 44 | $5,294 | $93 |
| Insertion of breathing sensor electrode or electrode array into chest wall | 14 | $5,156 | $368 |
| Removal of impacted ear wax | 69 | $3,058 | $36 |
| Short return visit | 38 | $1,835 | $43 |
| Diagnostic exam of voice box using a flexible endoscope | 21 | $1,114 | $53 |
| Professional service for multiple injections of allergen | 14 | $657 | $8 |
2020: 12 services
| Short return visit (20+ min) | 239 | $21,682 | $54 |
| New patient visit (30+ min) | 163 | $12,425 | $76 |
| Diagnostic exam of nasal passages using an endoscope | 38 | $7,508 | $127 |
| Removal of impacted ear wax | 84 | $3,597 | $34 |
| Diagnostic exam of voice box using a flexible endoscope | 31 | $3,322 | $92 |
| Professional service for preparation and provision of 1 or more antigens | 11 | $2,320 | $11 |
| Simple control of nose bleed | 16 | $2,211 | $105 |
| Return visit (30+ min) | 23 | $1,924 | $80 |
| New patient visit (45+ min) | 13 | $1,441 | $111 |
| Diagnostic exam of voice box using a flexible endoscope | 14 | $767 | $55 |
| Professional service for multiple injections of allergen | 18 | $675 | $8 |
| Short return visit | 15 | $539 | $36 |
2019: 13 services
| Short return visit (20+ min) | 229 | $21,538 | $52 |
| Diagnostic exam of nasal passages using an endoscope | 57 | $13,007 | $145 |
| New patient visit (30+ min) | 154 | $11,578 | $75 |
| Diagnostic exam of voice box using a flexible endoscope | 50 | $5,456 | $80 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 12 | $5,432 | $272 |
| Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | 11 | $4,086 | $371 |
| Removal of impacted ear wax | 67 | $2,619 | $32 |
| New patient visit (45+ min) | 17 | $2,141 | $126 |
| Simple control of nose bleed | 13 | $1,301 | $93 |
| Punch biopsy, first skin growth | 12 | $1,102 | $92 |
| Return visit (30+ min) | 14 | $1,045 | $70 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $876 | $80 |
| Short return visit | 13 | $416 | $30 |
2018: 12 services
| Short return visit (20+ min) | 245 | $21,979 | $51 |
| New patient visit (30+ min) | 181 | $13,401 | $74 |
| Diagnostic exam of nasal passages using an endoscope | 50 | $11,232 | $156 |
| Diagnostic exam of voice box using a flexible endoscope | 88 | $10,413 | $77 |
| New patient visit (45+ min) | 38 | $4,414 | $116 |
| Removal of impacted ear wax | 90 | $3,156 | $31 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,710 | $159 |
| Simple control of nose bleed | 17 | $2,212 | $92 |
| Long return visit (40+ min) | 13 | $1,436 | $103 |
| Biopsy of single growth of skin and/or tissue | 13 | $1,215 | $76 |
| Return visit (30+ min) | 16 | $1,085 | $68 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $555 | $31 |
2017: 11 services
| Short return visit (20+ min) | 227 | $20,738 | $54 |
| New patient visit (30+ min) | 241 | $18,867 | $78 |
| Diagnostic exam of nasal passages using an endoscope | 58 | $14,263 | $155 |
| Diagnostic exam of voice box using a flexible endoscope | 97 | $11,728 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $4,708 | $157 |
| Removal of impacted ear wax | 71 | $2,945 | $32 |
| Simple control of nose bleed | 27 | $2,028 | $65 |
| New patient visit (45+ min) | 16 | $2,026 | $127 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 26 | $1,351 | $31 |
| Diagnostic exam of voice box using a flexible endoscope | 14 | $848 | $53 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 14 | $529 | $38 |
2016: 5 services
| New patient visit (30+ min) | 76 | $6,226 | $82 |
| Short return visit (20+ min) | 69 | $5,428 | $55 |
| Diagnostic exam of voice box using a flexible endoscope | 37 | $3,684 | $88 |
| Diagnostic exam of nasal passages using an endoscope | 14 | $3,178 | $159 |
| New patient visit (30+ min) | 15 | $1,017 | $68 |
Medicaid work
$1,203 in 2024
Medicaid paid $1,203 for 40 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 40 | $1,203 |
| 2024 | 40 | 1 | 12 | $1,203 |
| 2021 | 187 | 4 | 28 | $6,444 |
| 2020 | 31 | 1 | 15 | $684 |
See the largest Medicaid services in earlier years
2021
| Short return visit (20+ min) | 142 | $3,729 |
| New patient visit (45+ min) | 17 | $1,314 |
| New patient visit (30+ min) | 13 | $814 |
| Return visit (30+ min) | 15 | $588 |
2020
| Short return visit (20+ min) | 31 | $684 |
Drugs they prescribed that Part D paid
$5,258
Pharmacies billed $5,258 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 34% of their Part D prescriptions (39 of 116) in 2024. A higher opioid share than 9 in 10 peers; the typical otolaryngology clinician is at 4%.
106 generic and fewer than 11 brand-name prescriptions · $5,258 in drug cost · 14 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Fluticasone Propionate | 14 | $151 | $11 |
| Oxycodone | 39 | $89 | $2 |
Year by year
| 2024 | 116 | 62 | 34% (39) | None | $5,258 |
| 2023 | 127 | 74 | 28% (36) | None | $9,066 |
| 2022 | 172 | 87 | 22% (37) | None | $6,051 |
| 2021 | 196 | 103 | 24% (47) | None | $3,112 |
| 2020 | 202 | 90 | 12% (25) | None | $3,084 |
| 2019 | 221 | 101 | 10% (23) | None | $5,430 |
| 2018 | 215 | 109 | 10% (21) | 7% | $6,778 |
| 2017 | 241 | 107 | 11% (27) | 5% | $7,101 |
| 2016 | 74 | 45 | 26% (19) | None | $1,749 |
| 2015 | 35 | 27 | 37% (13) | None | $872 |
| 2014 | 36 | 21 | None | None | $3,116 |
| 2013 | 83 | 46 | 28% (23) | None | $2,198 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Omeprazole | 14 | $226 | $16 |
| Fluticasone Propionate | 18 | $189 | $11 |
| Oxycodone | 36 | $82 | $2 |
2022: 4 drugs
| Famotidine | 15 | $585 | $39 |
| Omeprazole | 35 | $468 | $13 |
| Fluticasone Propionate | 31 | $363 | $12 |
| Oxycodone | 37 | $119 | $3 |
2021: 4 drugs
| Fluticasone Propionate | 30 | $552 | $18 |
| Omeprazole | 31 | $323 | $10 |
| Oxycodone | 46 | $226 | $5 |
| Pantoprazole | 16 | $93 | $6 |
2020: 3 drugs
| Fluticasone Propionate | 47 | $589 | $13 |
| Omeprazole | 55 | $497 | $9 |
| Oxycodone | 25 | $83 | $3 |
2019: 4 drugs
| Omeprazole | 65 | $730 | $11 |
| Fluticasone Propionate | 34 | $557 | $16 |
| Oxycodone | 23 | $286 | $12 |
| Prednisone | 19 | $113 | $6 |
2018: 5 drugs
| Fluticasone Propionate | 34 | $507 | $15 |
| Omeprazole | 51 | $411 | $8 |
| Ipratropium | 11 | $340 | $31 |
| Oxycodone | 21 | $234 | $11 |
| Prednisone | 14 | $71 | $5 |
2017: 7 drugs
| Ciprodex | 11 | $2,616 | $238 |
| Fluticasone Propionate | 46 | $500 | $11 |
| Omeprazole | 35 | $299 | $9 |
| Oxycodone | 26 | $177 | $7 |
| Amoxicillin-Clavulanate Potass | 11 | $159 | $14 |
| Prednisone | 20 | $114 | $6 |
| Cephalexin | 17 | $91 | $5 |
2016: 1 drug
| Cephalexin | 15 | $98 | $7 |
2013: 1 drug
| Oxycodone | 19 | $227 | $12 |
Money from drug and device companies
$4,781 in 2025
| 2025 | 28 | 131 | None | $4,781 |
| 2024 | 27 | 148 | $14,388 | $18,251 |
| 2023 | 28 | 126 | $2,375 | $6,517 |
| 2022 | 20 | 85 | $400 | $3,897 |
| 2021 | 10 | 35 | None | $919 |
| 2020 | 8 | 19 | None | $454 |
| 2019 | 10 | 24 | $175 | $766 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Inspire Medical Systems | Inspire | $1,125 | 35 payments
|
| Genzyme | Dupixent | $556 | 12 payments
|
| Medtronic | Propel | $502 | 3 payments
|
| Harmony Biosciences | Wakix | $294 | 8 payments
|
| Neurent Medical | Neuromark System | $252 | 3 payments
|
| Optinose US | Xhance | $241 | 6 payments
|
See all 130 published payments
| Inspire Medical Systems | Meals · 2025-12-29 | Inspire | $25 |
| Paratek Pharmaceuticals | Meals · 2025-12-17 | Xhance | $29 |
| Inspire Medical Systems | Meals · 2025-12-17 | Inspire | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-16 | Tezspire | $19 |
| GlaxoSmithKline | Meals · 2025-12-11 | Nucala | $19 |
| Neurent Medical | Meals · 2025-12-11 | Neuromark System | $42 |
| Genentech USA | Meals · 2025-12-10 | Xolair | $33 |
| Harmony Biosciences | Meals · 2025-12-08 | Wakix | $33 |
| Inspire Medical Systems | Meals · 2025-12-04 | Inspire | $9 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-18 | Fasenra | $23 |
| Paratek Pharmaceuticals | Meals · 2025-11-12 | Xhance | $25 |
| Stryker | Meals · 2025-11-11 | Scopis Ent | $164 |
| Novus Surgical Consultants | Meals · 2025-11-11 | None | $35 |
| Paratek Pharmaceuticals | Meals · 2025-11-10 | Xhance | $24 |
| Amgen | Meals · 2025-11-10 | Tezspire | $18 |
| Regeneron Healthcare Solutions | Meals · 2025-11-07 | Libtayo | $15 |
| Inspire Medical Systems | Meals · 2025-11-06 | Inspire | $6 |
| Harmony Biosciences | Meals · 2025-11-03 | Wakix | $50 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-29 | Fasenra | $14 |
| Inspire Medical Systems | Meals · 2025-10-29 | Inspire | $18 |
| Amgen | Meals · 2025-10-28 | Tezspire | $18 |
| Inspire Medical Systems | Meals · 2025-10-28 | Inspire | $15 |
| Regeneron Healthcare Solutions | Meals · 2025-10-22 | None | $97 |
| Axsome Therapeutics | Meals · 2025-10-21 | Sunosi | $18 |
| Inspire Medical Systems | Meals · 2025-10-16 | Inspire | $6 |
| Philips North America | Meals · 2025-10-14 | Vest Therapy Und | $20 |
| Hologic Sales and Service | Meals · 2025-10-09 | Coolseal Generator | $67 |
| Axsome Therapeutics | Meals · 2025-10-03 | Sunosi | $14 |
| Inspire Medical Systems | Meals · 2025-10-03 | Inspire | $28 |
| Genzyme | Meals · 2025-09-30 | Dupixent | $33 |
| Verona Pharma | Meals · 2025-09-19 | Ohtuvayre | $33 |
| Inspire Medical Systems | Meals · 2025-09-18 | Inspire | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-09 | Fasenra | $21 |
| Philips North America | Meals · 2025-09-08 | Vest Therapy Und | $22 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-03 | Tezspire | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-26 | Tezspire | $17 |
| Inspire Medical Systems | Meals · 2025-08-26 | Inspire | $32 |
| Inspire Medical Systems | Meals · 2025-08-21 | Inspire | $3 |
| Inspire Medical Systems | Meals · 2025-08-21 | Inspire | $6 |
| Inspire Medical Systems | Meals · 2025-08-19 | Inspire | $14 |
| GlaxoSmithKline | Meals · 2025-08-18 | Nucala | $19 |
| Philips North America | Meals · 2025-08-12 | Vest Therapy Und | $18 |
| Optinose US | Meals · 2025-08-06 | Xhance | $28 |
| Genzyme | Meals · 2025-08-04 | Dupixent | $4 |
| Inspire Medical Systems | Meals · 2025-08-01 | Inspire | $4 |
| Inspire Medical Systems | Meals · 2025-08-01 | Inspire | $13 |
| Inspire Medical Systems | Meals · 2025-07-31 | Inspire | $139 |
| Neurent Medical | Meals · 2025-07-28 | Neuromark System | $37 |
| Inspire Medical Systems | Meals · 2025-07-25 | Inspire | $28 |
| Harmony Biosciences | Meals · 2025-07-22 | Wakix | $28 |
| Phadia US | Meals · 2025-07-16 | Immunocap | $19 |
| Revance Therapeutics | Meals · 2025-07-16 | Daxxify | $45 |
| Optinose US | Meals · 2025-07-15 | Xhance | $109 |
| GlaxoSmithKline | Meals · 2025-07-08 | Nucala | $24 |
| Viatris Specialty | Meals · 2025-07-01 | Yupelri | $30 |
| Optinose US | Meals · 2025-06-25 | Xhance | $27 |
| Genzyme | Meals · 2025-06-24 | Dupixent | $27 |
| Verona Pharma | Meals · 2025-06-20 | Ohtuvayre | $30 |
| Inspire Medical Systems | Meals · 2025-06-19 | Inspire | $9 |
| Inspire Medical Systems | Meals · 2025-06-18 | Inspire | $15 |
| Inspire Medical Systems | Meals · 2025-06-18 | Inspire | $101 |
| Genzyme | Meals · 2025-06-17 | Dupixent | $96 |
| Phathom Pharmaceuticals | Meals · 2025-06-12 | Voquezna | $21 |
| Genzyme | Meals · 2025-06-10 | Dupixent | $62 |
| GlaxoSmithKline | Meals · 2025-06-09 | Nucala | $29 |
| Philips North America | Meals · 2025-06-09 | Vest Therapy Und | $23 |
| Axsome Therapeutics | Meals · 2025-06-06 | Sunosi | $20 |
| Inspire Medical Systems | Meals · 2025-06-05 | Inspire | $86 |
| Genzyme | Meals · 2025-06-04 | Dupixent | $29 |
| Harmony Biosciences | Meals · 2025-06-02 | Wakix | $45 |
| Inspire Medical Systems | Meals · 2025-06-02 | Inspire | $5 |
| Genzyme | Meals · 2025-05-30 | Dupixent | $5 |
| Mallinckrodt Hospital Products | Meals · 2025-05-27 | Acthar | $26 |
| Genzyme | Meals · 2025-05-20 | Dupixent | $30 |
| ANI Pharmaceuticals | Meals · 2025-05-13 | Purified Cortrophin Gel | $31 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-12 | Tezspire | $22 |
| Axsome Therapeutics | Meals · 2025-05-09 | Sunosi | $23 |
| GlaxoSmithKline | Meals · 2025-05-07 | Nucala | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-06 | Fasenra | $25 |
| Electromed | Meals · 2025-05-02 | Smartvest | $45 |
| Inspire Medical Systems | Meals · 2025-05-01 | Inspire | $6 |
| Inspire Medical Systems | Meals · 2025-04-30 | Inspire | $23 |
| Genzyme | Meals · 2025-04-29 | Dupixent | $37 |
| Optinose US | Meals · 2025-04-23 | Xhance | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-15 | Fasenra | $23 |
| Inspire Medical Systems | Meals · 2025-04-14 | Inspire | $28 |
| Optinose US | Meals · 2025-04-11 | Xhance | $25 |
| Genzyme | Meals · 2025-04-08 | Dupixent | $97 |
| Harmony Biosciences | Meals · 2025-04-07 | Wakix | $34 |
| Lilly USA | Meals · 2025-04-01 | Zepbound | $19 |
| Inspire Medical Systems | Meals · 2025-03-27 | Inspire | $5 |
| Phathom Pharmaceuticals | Meals · 2025-03-25 | Voquezna | $125 |
| Genzyme | Meals · 2025-03-25 | Dupixent | $21 |
| Inspire Medical Systems | Meals · 2025-03-25 | Inspire | $59 |
| Organogenesis | Meals · 2025-03-19 | Affinity | $18 |
| Viatris Specialty | Meals · 2025-03-18 | Yupelri | $31 |
| Phathom Pharmaceuticals | Meals · 2025-03-13 | Voquezna | $21 |
| Inspire Medical Systems | Meals · 2025-03-13 | Inspire | $5 |
| Inspire Medical Systems | Meals · 2025-03-12 | Inspire | $27 |
| Inspire Medical Systems | Meals · 2025-03-12 | Inspire | $130 |
| GlaxoSmithKline | Meals · 2025-03-11 | Nucala | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-03-11 | Dupixent | $32 |
| Harmony Biosciences | Meals · 2025-03-10 | Wakix | $44 |
| Novus Surgical Consultants | Meals · 2025-03-04 | None | $24 |
| Optinose US | Meals · 2025-03-03 | Xhance | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-03 | Fasenra | $2 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-03 | Fasenra | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-27 | Fasenra | $17 |
| Medtronic | Meals · 2025-02-27 | Propel | $177 |
| Medtronic | Meals · 2025-02-25 | Propel | $175 |
| Inspire Medical Systems | Meals · 2025-02-25 | Inspire | $107 |
| Neurent Medical | Meals · 2025-02-24 | Neuromark System | $172 |
| Inspire Medical Systems | Meals · 2025-02-20 | Inspire | $6 |
| Genzyme | Meals · 2025-02-18 | Dupixent | $113 |
| Viatris Specialty | Meals · 2025-02-14 | Yupelri | $24 |
| Philips North America | Meals · 2025-02-10 | Vest Therapy Und | $20 |
| Medtronic | Meals · 2025-02-06 | Sinuva | $150 |
| Pfizer | Meals · 2025-02-03 | Nurtec Odt | $16 |
| Viatris Specialty | Meals · 2025-01-31 | Yupelri | $32 |
| Inspire Medical Systems | Meals · 2025-01-30 | Inspire | $5 |
| Axsome Therapeutics | Meals · 2025-01-28 | Sunosi | $14 |
| Inspire Medical Systems | Meals · 2025-01-28 | Inspire | $119 |
| GlaxoSmithKline | Meals · 2025-01-22 | Nucala | $18 |
| Harmony Biosciences | Meals · 2025-01-20 | Wakix | $19 |
| Pfizer | Meals · 2025-01-17 | Nurtec Odt | $16 |
| Phathom Pharmaceuticals | Meals · 2025-01-16 | Voquezna | $25 |
| GlaxoSmithKline | Meals · 2025-01-14 | Nucala | $26 |
| Amgen | Meals · 2025-01-07 | Tezspire | $18 |
| Harmony Biosciences | Meals · 2025-01-03 | Wakix | $41 |
| Inspire Medical Systems | Meals · 2025-01-02 | Inspire | $6 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $18,251
| Inspire Medical Systems | Inspire | $14,344 | 32 payments
|
| Neurent Medical | Neuromark Device | $1,260 | 8 payments
|
| Optinose US | Xhance | $335 | 10 payments
|
| Genzyme | Dupixent | $232 | 8 payments
|
| AstraZeneca Pharmaceuticals LP | Airsupra | $219 | 13 payments
|
| Philips North America | (Ak6) Vest Therapy | $191 | 11 payments
|
| Regeneron Healthcare Solutions | Dupixent | $188 | 4 payments
|
| Avadel CNS Pharmaceuticals | Lumryz | $174 | 9 payments
|
| Phathom Pharmaceuticals | Voquezna | $165 | 4 payments
|
| Harmony Biosciences | Wakix | $152 | 6 payments
|
| GlaxoSmithKline | Nucala | $130 | 6 payments
|
| Medtronic | Pteye Parathyroid Detection System | $121 | 3 payments
|
| Pfizer | Nurtec Odt | $90 | 6 payments
|
| Axsome Therapeutics | Sunosi | $88 | 5 payments
|
| Kerecis | Kerecis Omega3 Surgiclose | $80 | 1 payment
|
| Jazz Pharmaceuticals | Xywav | $79 | 3 payments
|
| Organogenesis | Affinity | $68 | 2 payments
|
| Mallinckrodt Hospital Products | Acthar | $61 | 3 payments
|
| Aerin Medical | Vivaer Stylus | $55 | 2 payments
|
| Actelion Pharmaceuticals US | Opsumit | $42 | 2 payments
|
| Smith+Nephew | Halo | $39 | 1 payment
|
| ConvaTec | Innovamatrix Ac | $33 | 1 payment
|
| Hologic Sales and Service | Coolseal Generator | $31 | 2 payments
|
| Stryker | Scopis Ent | $24 | 1 payment
|
| Rayner Intraocular Lenses | Omidria | $20 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $17 | 1 payment
|
| Axogen | Avance Nerve Graft | $13 | 1 payment
|
2023: $6,517
| Inspire Medical Systems | Inspire | $3,221 | 27 payments
|
| Neurent Medical | Neuromark Device | $831 | 10 payments
|
| GlaxoSmithKline | Nucala | $405 | 16 payments
|
| Optinose US | Xhance | $392 | 12 payments
|
| Kerecis | Kerecis Omega3 Surgiclose | $256 | 1 payment
|
| Harmony Biosciences | Wakix | $152 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $147 | 6 payments
|
| Lumenis BE | M22 | $131 | 1 payment
|
| Actelion Pharmaceuticals US | Opsumit | $110 | 4 payments
|
| Aerin Medical | Vivaer Stylus | $107 | 3 payments
|
| Axsome Therapeutics | Sunosi | $95 | 5 payments
|
| Organogenesis | Puraply | $73 | 2 payments
|
| Genzyme | Dupixent | $73 | 3 payments
|
| Philips Electronics North America | (8874) Incourage | $66 | 4 payments
|
| Merck Sharp & Dohme | Belsomra | $63 | 4 payments
|
| Jazz Pharmaceuticals | Xywav | $58 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $45 | 2 payments
|
| Regeneron Healthcare Solutions | Libtayo | $45 | 2 payments
|
| Mallinckrodt Hospital Products | Acthar | $35 | 2 payments
|
| Genentech USA | Xolair | $34 | 1 payment
|
| KLS-Martin L.P. | None | $33 | 1 payment
|
| Blueprint Medicines | Ayvakit | $31 | 1 payment
|
| Idorsia Pharmaceuticals US | Quviviq | $30 | 2 payments
|
| PolyNovo North America | None | $22 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $19 | 1 payment
|
| Avadel CNS Pharmaceuticals | Lumryz | $14 | 1 payment
|
| Hikma Pharmaceuticals USA | Ryaltris | $14 | 1 payment
|
| Hologic Sales and Service | Coolseal Generator | $13 | 1 payment
|
2022: $3,897
| Inspire Medical Systems | Inspire Upper Airway Stimulation System | $1,122 | 2 payments
|
| Aerin Medical | Vivaer Stylus | $605 | 4 payments
|
| GlaxoSmithKline | Nucala | $403 | 11 payments
|
| Neurent Medical | Neuromark Device | $344 | 3 payments
|
| Genzyme | Dupixent | $322 | 10 payments
|
| OptiNose US | Xhance | $321 | 11 payments
|
| Intersect ENT | Propel | $126 | 2 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $112 | 6 payments
|
| Stryker | 1688 | $95 | 3 payments
|
| Organogenesis | Puraply | $91 | 4 payments
|
| Acclarent | Acclarent Aera | $74 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $57 | 3 payments
|
| Harmony Biosciences | Wakix | $55 | 3 payments
|
| Galderma Laboratories L.P. | None | $46 | 2 payments
|
| Actelion Pharmaceuticals US | Opsumit | $37 | 2 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $27 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $17 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Tezspire | $15 | 1 payment
|
| kaleo | Auvi-Q | $15 | 1 payment
|
| ALK-Abello | Odactra | $13 | 1 payment
|
2021: $919
| Inspire Medical Systems | Inspire Upper Airway Stimulation System | $304 | 1 payment
|
| GlaxoSmithKline | Nucala | $192 | 6 payments
|
| Optinose US | Xhance | $122 | 8 payments
|
| Intersect ENT | Propel | $74 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $69 | 3 payments
|
| Genzyme | Dupixent | $55 | 3 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $34 | 2 payments
|
| Acclarent | Acclarent Navwire | $29 | 1 payment
|
| Stryker | Xpress Ent Dilation System | $28 | 1 payment
|
| Merck Sharp & Dohme | None | $13 | 1 payment
|
2020: $454
| Inspire Medical Systems | Inspire Upper Airway Stimulation System | $179 | 1 payment
|
| OptiNose US | Xhance | $90 | 6 payments
|
| Stryker | Entellus - Fiagon Sinus Navigation System | $53 | 2 payments
|
| Intersect ENT | Propel | $42 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $28 | 1 payment
|
| Smith+Nephew | Procise Tonsil | $27 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis Itec Preloaded Delivery System | $21 | 1 payment
|
| ALK-Abello | Otiprio | $15 | 1 payment
|
2019: $766
| Intersect ENT | Propel | $220 | 4 payments
|
| Inspire Medical Systems | Inspire Upper Airway Stimulation System | $200 | 1 payment
|
| Stryker | Entellus - Xpress Ent Dilation System | $108 | 4 payments
|
| OptiNose US | Xhance | $53 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $53 | 2 payments
|
| Galderma Laboratories L.P. | None | $52 | 2 payments
|
| Genzyme | Dupixent | $25 | 1 payment
|
| Ethicon US | Surgiflo Hemostatic Matrix Family of Products | $22 | 1 payment
|
| Acclarent | Acclarent Navwire Sinus Navigation Guidewire | $21 | 1 payment
|
| Atos Medical | None | $11 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 95.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1194046151
- Licence
- CA A136329California A136329: Cancelled
- Trained
- University of South Florida College of Medicine, 2010
- Group
- Specialty Physician Associates, LLC · St Lukes Physician Group Inc
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2010-06-14
- NPI last updated
- 2015-12-04
This is when the NPI record was last certified, not a medical board exam.